Overcoming the Bottlenecks in Drug Discovery and Development
20 - 21 March 2014
DSIN/Ranbaxy, Gurgaon, India
The Royal Society of Chemistry (RSC), Daiichi Sankyo India Pharma Private Limited (DSIN) and Ranbaxy Laboratories Limited (RLL) are pleased to announce an R&D Conference on Overcoming the Bottlenecks in Drug Discovery and Development which will be held in Gurgaon, Haryana, India from 20-21 March 2014.
The objective of the conference is to raise awareness of the bottlenecks in drug discovery and formulation research, and to showcase the scientific advances being used to overcome such problems. Eminent international scientists from industry and academia will deliver talks on modern trends in drug discovery and development research with a focus on advancing and sharing excellence in medicinal chemistry and pharmaceutical science.
The conference will consist of oral presentations, several short oral poster talks, a poster session and a panel discussion covering "the role of open innovation in developing medicines". Scientific excellence and networking opportunities are important aspects of the conference. We invite you to Gurgaon in 2014 and look forward to your participation at this unique event.
An invite only training workshop will be held after the conference.
- Biological target identification
- Chemical hit identification
- Pharmaceutical research
- Chemical hit-to-lead optimization
- Ian Cliffe, DSIN
- Andy Davis, AstraZeneca
- Subodh Deshmukh, RLL
- Jitendra Sattigeri, DSIN
- Simon Ward, University of Sussex
Contact and Further Information
RSC Representative India, International Development
Tel: +91 80 4211 0385
Royal Society of Chemistry, Thomas Graham House, Science Park, Milton Road, Cambridge, CB4 0WF
Tel: +44 (0) 1223 432380/432254
Fax: +44 (0) 1223 423623